Literature DB >> 5043412

Tumor dormancy in vivo by prevention of neovascularization.

M A Gimbrone, S B Leapman, R S Cotran, J Folkman.   

Abstract

Dormant solid tumors were produced in vivo by prevention of neovascularization. When small fragments of anaplastic Brown-Pearce carcinoma were implanted directly on the iris in susceptible rabbits, they always vascularized. A characteristic growth pattern, consisting of prevascular, vascular, and late phases, was observed, which terminated with destruction of the eye within 2 wk. The beginning of exponential volume increase was shown to coincide with vascularization of the implant, as demonstrated by perfusion with intravenous fluorescein and by histologic sections. In contrast, implants placed in the anterior chamber, at a distance from the iris, did not become vascularized. After initial growth into spheroids, they remained arrested at a small size comparable to prevascular iris implants, for periods as long as 6 wk. Although dormant in terms of expansion, these avascular tumors contained a population of viable and mitotically active tumor cells. When reimplanted on the iris, vascularization was followed by rapid, invasive growth. These observations suggest that neovascularization is a necessary condition for malignant growth of a solid tumor. When a small mass of tumor cells is prevented from eliciting new vessel ingrowth from surrounding host tissues, population dormancy results. These data suggest that the specific blockade of tumor-induced angiogenesis may be an effective means of controlling neoplastic growth.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5043412      PMCID: PMC2139203          DOI: 10.1084/jem.136.2.261

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Experimental studies of factors influencing hepatic metastases. III. Effect of surgical trauma with special reference to liver injury.

Authors:  B FISHER; E R FISHER
Journal:  Ann Surg       Date:  1959-10       Impact factor: 12.969

2.  Experimental evidence in support of the dormant tumor cell.

Authors:  B FISHER; E R FISHER
Journal:  Science       Date:  1959-10-09       Impact factor: 47.728

3.  The time interval between tumor inoculation and metastatic spread to the lymph nodes.

Authors:  H P PLENK; F M SORENSON; E J EICHWALD
Journal:  Cancer Res       Date:  1954-09       Impact factor: 12.701

4.  The dormant cancer cell.

Authors:  G HADFIELD
Journal:  Br Med J       Date:  1954-09-11

Review 5.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

6.  Anti-angiogenesis: new concept for therapy of solid tumors.

Authors:  J Folkman
Journal:  Ann Surg       Date:  1972-03       Impact factor: 12.969

7.  Studies of dormant tumor cells.

Authors:  E V Sugarbaker; A S Ketcham; A M Cohen
Journal:  Cancer       Date:  1971-09       Impact factor: 6.860

8.  Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment.

Authors:  J Folkman; P Cole; S Zimmerman
Journal:  Ann Surg       Date:  1966-09       Impact factor: 12.969

9.  Isolation of a tumor factor responsible for angiogenesis.

Authors:  J Folkman; E Merler; C Abernathy; G Williams
Journal:  J Exp Med       Date:  1971-02-01       Impact factor: 14.307

10.  HETEROLOGOUS TRANSPLANTATION OF MAMMALIAN TUMORS : I. THE TRANSFER OF RABBIT TUMORS TO ALIEN SPECIES.

Authors:  H S Greene
Journal:  J Exp Med       Date:  1941-03-31       Impact factor: 14.307

  10 in total
  207 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

Review 2.  Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.

Authors:  A J Hayes; L Y Li; M E Lippman
Journal:  BMJ       Date:  1999-03-27

3.  Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels.

Authors:  D H Ausprunk; D R Knighton; J Folkman
Journal:  Am J Pathol       Date:  1975-06       Impact factor: 4.307

4.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

5.  Dynamic remodeling of the vascular bed precedes tumor growth: MLS ovarian carcinoma spheroids implanted in nude mice.

Authors:  A Gilead; M Neeman
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

Review 6.  Hypoxic tumor microenvironment: Implications for cancer therapy.

Authors:  Sukanya Roy; Subhashree Kumaravel; Ankith Sharma; Camille L Duran; Kayla J Bayless; Sanjukta Chakraborty
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-27

Review 7.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

8.  Focal adhesion kinase inhibitors are potent anti-angiogenic agents.

Authors:  Miguel A Cabrita; Laura M Jones; Jennifer L Quizi; Luc A Sabourin; Bruce C McKay; Christina L Addison
Journal:  Mol Oncol       Date:  2011-10-20       Impact factor: 6.603

9.  High eIF4E, VEGF, and microvessel density in stage I to III breast cancer.

Authors:  Kerry Byrnes; Stephen White; Quyen Chu; Carol Meschonat; Herbert Yu; Lester W Johnson; Arrigo Debenedetti; Fleurette Abreo; Richard H Turnage; John C McDonald; Benjamin D Li
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

Review 10.  Invasiveness of transformed bladder epithelial cells.

Authors:  J F Kieler
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.